A six-year-old boy from Santa Maria, Portugal has passed away days after receiving the first dose of the experimental Pfizer COVID-19 injection.
The hospital said in a statement that the child was admitted to Hospital de Santa Maria on Saturday with “a condition of cardiorespiratory arrest.”
It’s suspected the boy had an adverse reaction from the injection taken days before his tragic death.
On Monday, Central Lisbon University Hospital Centre (CHULN) announced that an unnamed six-year-old boy had died on Sunday, January 16th as a result of a cardiac arrest.
The COVID World shared their press release:
Central Lisbon University Hospital Centre confirms the death of a six-year-old boy on Sunday, January 16th with a positive test for Sars-CoV-2, who was admitted to Santa Maria Hospital a day earlier with a cardiorespiratory arrest. The causes of death are being analyzed.
The child had received the first dose of the vaccine against Covid-19, and CHULN has notified the case to Infarmed (Portugal’s National Institute of Pharmacy and Medicines) and the Directorate-General for Health.
Infarmed issued a statement, saying:
“We confirm that we received the notification on Monday, January 17th of a suspected adverse reaction and this is being treated by Infarmed in conjunction with the regional unit of pharmacological vigilance of Lisbon, Setúbal and Santarém.”
Experts from the agency will carry out an autopsy and present the results as they become available.
Portugal began inoculating 5-11-year-old children on December 18th after the country’s health authority DGS approved the Pfizer COVID-19 jab on December 7th for the age group.
Portugal’s health authority DGS gave the green light on Tuesday for the use of the Pfizer-BioNTech’s COVID-19 vaccine for children between the ages of five and 11.
A total of 637,907 children in Portugal are eligible to receive the shot, and DGS said priority would be given to those with pre-existing health conditions. The first batch of vaccines for children arrives on Monday.
The DGS decision, which was widely expected, came after the EU’s drug regulator EMA took the same step on Nov. 25, saying the vaccine should be given as an injection in the upper arm in two 10 microgram doses, three weeks apart.
SourceFollow us in social media